Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
26.00    0.50 (1.96%)
Bid:
25.00
Ask:
27.00
Spread: 2.00 (8.00%)
Market Cap: £12.38m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Result of Placing

29 Jan 2019 12:45

RNS Number : 4297O
Pennant International Group PLC
29 January 2019
Β 

For immediate release

Β 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Β 

Pennant International Group plc

("Pennant", the "Company" or the "Group")Β 

Β 

Results of the Placing

Β 

Further to the accelerated bookbuilding process announced earlier today, Pennant International Group plc is pleased to announce the results of an oversubscribed placing with institutional investors of 2,281,110 Placing Shares, comprising 1,647,160 Fundraising Shares and 633,950 Available Option Shares. The Placing was conducted at a price of 110 pence per Placing Share. The Placing Price represents a discount of 3.93 per cent. to the closing price on 28 January 2019, the last trading day prior to this announcement.

Β 

The gross proceeds of the Fundraising amounting to Β£1.8 million (before expenses) together with the proceeds of the exercise of the 690,000 share options amounting to approximately Β£331,525 will predominantly be used to fund the potential Acquisition and to facilitate further new product development, as detailed in the Company's earlier announcement today. A further announcement will be made about the Acquisition in due course.

Β 

Application for admission to trading on AIM for 2,337,160Β New Ordinary Shares (comprising 1,647,160 Fundraising Shares and 690,000 Option Shares) being issued pursuant to the Fundraising and the exercise of share options has been made and Admission is expected to take place on 1 February 2019. The New Ordinary Shares will rank pari passu with the Existing Ordinary Shares in issue. The New Ordinary Shares will represent approximately 6.48 per cent. of the Enlarged Issued Share Capital on Admission (assuming no other issuance of ordinary shares prior to Admission).

Β 

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the New Ordinary Shares, its issued share capital will comprise 36,040,693 Ordinary Shares of 5 pence each. All of these Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in Treasury. The total number of voting rights in the Company will therefore be 36,040,693Β on Admission.

Β 

Pennant's Chief Executive Officer, Phil Walker, said: "We are delighted by the support we have received for this fundraising which will enable us to accelerate our Group strategy of increasing both commercial and recurring revenues through the planned Acquisition and further investment in innovative new products."

Β 

Terms used in this Announcement shall have the meanings given to such terms in the definitions section of the appendix to the announcement made by the Company at 7.00 a.m. this morning.

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Enquiries:

Β 

Β 

Pennant International Group plc

Β 

Simon Moore (Chairman)

+44 (0) 1452 714914

Philip Walker (Chief Executive Officer)

+44 (0) 1452 714914

Β 

Β 

WH Ireland Limited (Nominated Adviser and Broker)

Β 

Mike Coe / Chris Savidge (Corporate Finance)

+44 (0) 117 945 3470

Jasper Berry / Adam Pollock (Corporate Broking)

+44 (0) 207 220 1666

Β 

Β 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann / Tom Cooper

+44 (0) 207 933 8780

+44 (0) 776 880 7631

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
ROILKLFLKFFZBBX
Date   Source Headline
12th Jun 20267:00 amRNSMultiyear Auxilium Services Contract Award
4th Jun 20267:00 amRNS-RLaunch of Auxilium Phase 3
20th May 20263:18 pmRNSHolding(s) in Company
19th May 20267:20 amRNS-R1st conversion services contract & Siemens update
14th May 20267:00 amRNSDirector dealing
13th May 20267:00 amRNSGrant of Options
11th May 20267:00 amRNSTraining Systems Contract Win
8th May 202611:56 amRNSResult of AGM
21st Apr 20262:05 pmRNSHolding(s) in Company
1st Apr 20262:54 pmRNSNotice of AGM & Posting of Accounts
31st Mar 20265:00 pmRNSTotal Voting Rights
26th Mar 20267:00 amRNSIssue of Equity
23rd Mar 20267:00 amRNSFinal Results & Notice of Investor Presentation
2nd Feb 20267:00 amRNSTraining Systems Contract Win
19th Jan 20267:00 amRNSTrading & Strategy Update, Notice of Results
15th Jan 20267:00 amRNSDirectorate change
12th Dec 20253:34 pmRNSDirector Dealing
1st Dec 20251:36 pmRNSDirector Dealing
27th Nov 20259:40 amRNSHolding(s) in Company
25th Nov 202512:40 pmRNSGenFly Contract Award - valued at up to £5.75m
24th Oct 202511:15 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSShareholder Loan
8th Oct 202510:36 amRNSContract wins
1st Oct 20259:39 amRNSTotal Voting Rights
25th Sep 202512:59 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSSubscription update and closing & TVR
16th Sep 20257:01 amRNSProposed Underwritten Subscription to raise £1.25m
16th Sep 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
14th Aug 20257:00 amRNSChange of Adviser
11th Aug 20253:01 pmRNSHolding(s) in Company
8th Aug 20257:00 amRNSTrading Update & Notice of Results
14th Jul 20257:00 amRNSGlobal Partner Appointed & Auxilium Presentation
3rd Jul 20257:00 amRNSBusiness Update
6th Jun 20251:08 pmRNSResult of AGM
8th May 202512:30 pmRNSNotice of AGM & Posting of Accounts
24th Apr 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
9th Apr 20257:00 amRNSGenFly Contract Update
8th Apr 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
7th Apr 20257:00 amRNSProperty Disposal Programme Update
11th Mar 20252:25 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSProperty Disposal Programme Update
3rd Feb 20251:41 pmRNSDirector Dealings
16th Dec 202410:49 amRNSHolding(s) in Company
12th Dec 20247:00 amRNSAward of Options
10th Dec 20247:00 amRNSTrading Statement, Business Update & Investor Pres
20th Nov 20247:00 amRNSAppointment of CFO
14th Nov 20242:47 pmRNSHolding(s) in Company
6th Nov 20244:34 pmRNSHolding(s) in Company
23rd Oct 20243:56 pmRNSContracts Update
22nd Oct 20245:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.